Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 1999
Business Overview: A global leader in science and technology operating through approximately 20 strategic business units across nine reportable segments: Agriculture & Nutrition, Nylon Enterprise, Performance Coatings & Polymers, Pharmaceuticals, Pigments & Chemicals, Pioneer, Polyester Enterprise, Specialty Fibers, and Specialty Polymers. Operations span approximately 65 countries with 49% of sales derived from outside the United States. Total worldwide employment was approximately 94,000 at year-end.
Key Financial Metrics and Strategic Transactions
Strategic Transactions in 1999:
- Acquisition of Herberts: Finalized in February for $1.7 billion (cash and debt assumed), making DuPont the world's largest automotive coatings business.
- Divestiture of Conoco: Completed in August via a tax-free split-off. Shareholders exchanged 147,980,872 DuPont shares for Conoco Class B shares, realizing approximately $21 billion in value. Conoco is reported as discontinued operations.
- Acquisition of Pioneer Hi-Bred: Completed in October, acquiring the remaining 80% stake for a transaction valued at $7.7 billion, securing the world's largest seed company.
Financial Data Availability: The provided text serves as the cover and index for the 10-K. Specific consolidated financial metrics (Revenue, Net Income, Cash Flow, Debt, Margins) are not present in the input text. The document states that this data is incorporated by reference from the "1999 Annual Report to Stockholders" (Exhibit 13), specifically on pages 72-73 for selected financial data and pages 43-46 for full financial statements.
Material Changes and Operational Highlights
- Portfolio Realignment: The company executed a major strategic shift by exiting the energy business (Conoco) and significantly expanding its bioscience footprint through the Pioneer acquisition.
- Segment Structure: The company now operates nine reportable segments. The "Other" segment, representing less than 2% of sales, includes divested businesses and global services.
- Capacity Utilization: Sales as a percent of capacity were 83% in 1999, compared to 82% in 1998 and 88% in 1997.
- Intellectual Property: The company holds approximately 18,000 patents worldwide with over 16,000 pending applications. In 1999, it was granted nearly 350 U.S. patents and 1,500 international patents.
Outlook, Risks, and Contingencies
Management Outlook:
- Research and development expenses are expected to increase in 2000, with a growing emphasis on bioscience-related R&D.
- The company aims to renew its pipeline of new products and bring them to market, though success depends on regulatory approvals and market acceptance.
Key Risks and Contingencies:
- Legal Proceedings (Benlate): Approximately 150 lawsuits remain pending regarding crop damage allegedly caused by Benlate(R) 50 DF fungicide. While management believes the product did not cause the damage, ultimate liabilities could be significant to the Crop Protection business results.
- Environmental Matters: The company faces ongoing regulatory actions, including a $1.9 million proposed EPA penalty for triazine herbicide labeling and a DOJ suit regarding a 1995 oleum release in Kentucky (settlement offer of $2.7 million contested). A 1997 HF release in Louisville is also subject to DOJ action (proposed $1.7 million fine contested).
- Market Risks: Results are sensitive to foreign currency exchange rates, interest rates, and hydrocarbon feedstock prices. The Agriculture & Nutrition and Pioneer segments are highly seasonal and dependent on weather conditions.
- Patent Litigation: The Pioneer segment is involved in several lawsuits regarding intellectual property rights for corn and soybean products.
Investor Verification Checklist
- Consolidated Financial Statements: Verify total revenue, net income, and cash flow figures in Exhibit 13 (pages 43-46) as they are not in the main text.
- Discontinued Operations Impact: Confirm the specific financial impact of the Conoco divestiture on 1999 earnings versus continuing operations.
- Benlate Litigation Accruals: Review the balance sheet notes for the specific amount accrued for Benlate(R) 50 DF liabilities and the potential for additional charges.
- Segment Performance: Analyze the individual performance of the new Pioneer segment and the Performance Coatings & Polymers segment (post-Herberts) in the segment information tables (Exhibit 13, pages 68-71).
- R&D Expenditure Trends: Verify the year-over-year increase in R&D spending as indicated in the Five-Year Financial Review (Exhibit 13, page 73).